Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L H Einhorn

Cisplatin, Doxorubicin, and Cyclophosphamide Plus Thoracic Radiation Therapy for Limited-Stage Unresectable Thymoma: An Intergroup Trial.

Journal of Clinical Oncology

English

Related publications

Cisplatin Versus Cisplatin Plus Doxorubicin for Standard-Risk Hepatoblastoma

New England Journal of Medicine

Medicine

2009

English

Cisplatin, Vindesine, and Concomitant Radiation Therapy for Unresectable Non-Small Cell Lung Cancer.

Japanese Journal of Lung Cancer

English

Radiation Therapy for Unresectable Pancreatic Adenocarcinoma

JAMA Surgery

Surgery

2015

English

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Journal of Clinical Oncology

English

Sorafenib or Placebo Plus TACE With Doxorubicin-Eluting Beads for Intermediate Stage HCC: The SPACE Trial

Journal of Hepatology

Hepatology

2016

English

Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-Ii Study of the SWOG (S0414)

Journal of Thoracic Oncology

English

P1.14-03 Phase II Trial of Amrubicin and Cisplatin Chemotherapy for Invasive Thymoma: WJOG5509L

Journal of Thoracic Oncology

English

A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596): A Trial of the Eastern Cooperative Oncology Group

Journal of Thoracic Oncology

English

Randomized Comparison of Doxorubicin Alone Versus Ifosfamide Plus Doxorubicin or Mitomycin, Doxorubicin, and Cisplatin Against Advanced Soft Tissue Sarcomas.

Journal of Clinical Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L H Einhorn

Cisplatin, Doxorubicin, and Cyclophosphamide Plus Thoracic Radiation Therapy for Limited-Stage Unresectable Thymoma: An Intergroup Trial.

Related publications

Cisplatin Versus Cisplatin Plus Doxorubicin for Standard-Risk Hepatoblastoma

Cisplatin, Vindesine, and Concomitant Radiation Therapy for Unresectable Non-Small Cell Lung Cancer.

Radiation Therapy for Unresectable Pancreatic Adenocarcinoma

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Sorafenib or Placebo Plus TACE With Doxorubicin-Eluting Beads for Intermediate Stage HCC: The SPACE Trial

Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-Ii Study of the SWOG (S0414)

P1.14-03 Phase II Trial of Amrubicin and Cisplatin Chemotherapy for Invasive Thymoma: WJOG5509L

A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596): A Trial of the Eastern Cooperative Oncology Group

Randomized Comparison of Doxorubicin Alone Versus Ifosfamide Plus Doxorubicin or Mitomycin, Doxorubicin, and Cisplatin Against Advanced Soft Tissue Sarcomas.